Clinical trial

Valor II: The Valiant Thoracic Stent Graft System Clinical Study

NCT00413231 · Medtronic Cardiovascular, Industry · Completed

Key facts

NCT number NCT00413231
Title Valor II: The Valiant Thoracic Stent Graft System Clinical Study
Official title The Valiant Thoracic Stent Graft System. The Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft System in the Treatment of Descending Thoracic Aneurysms of Degenerative Etiology in Subjects Who Are Candidates for Endovascular Repair.
Lead sponsor Medtronic Cardiovascular, Industry
Status Completed
Study type Interventional
Conditions Thoracic Aortic Aneurysm
Intervention type Device
Interventions Valiant Thoracic Stent Graft System
Enrollment 160
Start date Dec 1, 2006
Primary completion Aug 1, 2010
Completion Oct 1, 2014
First posted Dec 19, 2006
Last update posted Nov 3, 2021
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies